Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation (Details Narrative)

v3.19.1
Stock-Based Compensation (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Nov. 30, 2018
Jul. 31, 2018
Jun. 30, 2018
May 31, 2018
Feb. 28, 2018
Jan. 31, 2018
Dec. 31, 2018
Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Stock-based compensation expense             $ 1,228,699 $ 1,048,127
2014 Long Term Incentive Equity Plan [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of common stock authorized             5,951,081  
Shares of common stock available for grant of stock options             500,854  
Weighted average remaining contractual term of stock options outstanding             8 years 3 months 19 days  
Weighted average remaining contractual term of stock options vested and exercisable             7 years 9 months 18 days  
Number of options granted             1,585,324 380,000
Contractual term of stock options             10 years  
Exercise price per share             $ 2.01 $ 5.35
Number of stock options forfeited             195,108 76,389
Total unrecognized stock-based compensation expense             $ 1,400,000  
Period for recognition of unrecognized compensation expense             1 year 6 months  
2014 Long Term Incentive Equity Plan [Member] | Employment Agreement [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of options granted             700,000  
First vesting date             Mar. 15, 2020  
Final vesting date             Mar. 15, 2022  
2014 Long Term Incentive Equity Plan [Member] | EsoCheck Technology [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of options granted       75,000        
Vesting portion of stock options       Quarterly basis commencing June 30, 2018 and ending March 31, 2021        
2014 Long Term Incentive Equity Plan [Member] | Lucid Diagnostics Inc [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Stock-based compensation expense             $ 12,485  
2014 Long Term Incentive Equity Plan [Member] | New Hire Employee [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of options granted 50,000 195,108       175,000    
Exercise price per share $ 0.97 $ 1.58       $ 2.96    
Vesting portion of stock options Quarterly basis commencing December 31, 2018 and ending September 30, 2021 Quarterly basis commencing September 30, 2018 and ending June 30, 2021       Quarterly basis commencing March 31, 2018 and ending December 31, 2020    
2014 Long Term Incentive Equity Plan [Member] | New Hire Employee [Member] | March 7, 2019 [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of options granted             150,000  
Exercise price per share             $ 1.00  
Vesting portion of stock options             Quarterly basis commencing March 31, 2019 and ending December 31, 2021  
Vesting period of stock options             10 years  
2014 Long Term Incentive Equity Plan [Member] | Non-Executive Board of Directors [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of options granted         500,000      
Exercise price per share         $ 2.01      
Vesting portion of stock options         Quarterly basis commencing March 31, 2018 and ending December 31, 2020      
2014 Long Term Incentive Equity Plan [Member] | Employees [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of options granted         590,216      
Exercise price per share         $ 2.01      
2014 Long Term Incentive Equity Plan [Member] | Employees [Member] | March 7, 2019 [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of options granted             800,000  
2014 Long Term Incentive Equity Plan [Member] | One Non-Employee [Member] | EsoCheck Technology [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of options granted       25,000        
Exercise price per share       $ 1.59        
2014 Long Term Incentive Equity Plan [Member] | Two Non-Employee [Member] | EsoCheck Technology [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of options granted       25,000        
Exercise price per share       $ 1.59        
2014 Long Term Incentive Equity Plan [Member] | Three Non-Employee [Member] | EsoCheck Technology [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of options granted       25,000        
Exercise price per share       $ 1.59        
2014 Long Term Incentive Equity Plan [Member] | Board of Directors [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of stock options forfeited         195,108      
2014 Long Term Incentive Equity Plan [Member] | Employees and Non-Executive Members of Board of Directors [Member] | March 7, 2019 [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of options granted             1,600,000  
Exercise price per share             $ 1.00  
Vesting portion of stock options             Quarterly basis commencing March 31, 2019 and ending December 31, 2021  
Vesting period of stock options             10 years  
2014 Long Term Incentive Equity Plan [Member] | Non-Executive Members of Board of Directors [Member] | March 7, 2019 [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of options granted             800,000  
2014 Long Term Incentive Equity Plan [Member] | Employees and Members of Board of Directors [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Weighted average fair value of stock options             $ 1.21 $ 2.62
2014 Long Term Incentive Equity Plan [Member] | Non-employees [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Weighted average fair value of stock options             $ 1.97 $ 2.80
2018 Stock Plan [Member] | Lucid Diagnostics Inc [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of common stock authorized             2,000,000  
Shares of common stock available for grant of stock options             1,625,000  
Weighted average remaining contractual term of stock options outstanding             9 years 4 months 24 days  
Number of options granted             375,000  
Exercise price per share             $ 0.60  
Number of stock options forfeited              
Total unrecognized stock-based compensation expense             $ 152,000  
Period for recognition of unrecognized compensation expense             2 years 3 months 19 days  
Expected dividend yield             $ 0.00  
2018 Stock Plan [Member] | Contract Development and Manufacturing Organization [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of options granted     75,000          
Exercise price per share     $ 1.00          
Vesting portion of stock options     Quarterly basis commencing September 30, 2018 and ending June 30, 2021          
2018 Stock Plan [Member] | Three Non-Employee [Member] | EsoCheck Technology [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of options granted       100,000        
Exercise price per share       $ 0.50        
Vesting portion of stock options       Quarterly basis commencing June 30, 2018 and ending March 31, 2021        
2018 Long-Term Incentive Equity Plan [Member] | Lucid Diagnostics Inc [Member] | February 18, 2019 [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of options granted             300,000  
Exercise price per share             $ 1.00  
2018 Long-Term Incentive Equity Plan [Member] | Lucid Diagnostics Inc [Member] | February 18, 2019 [Member] | Vesting Immediately [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of options granted             200,000  
Vesting portion of stock options             Vesting immediately  
2018 Long-Term Incentive Equity Plan [Member] | Lucid Diagnostics Inc [Member] | February 18, 2019 [Member] | Vesting on a Quarterly Basis [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of options granted             100,000  
Vesting portion of stock options             Quarterly basis commencing March 31, 2019 and ending December 31, 2021  
Vesting period of stock options             10 years  
2018 Long-Term Incentive Equity Plan [Member] | New Hire Employee [Member] | Lucid Diagnostics Inc [Member] | February 18, 2019 [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of options granted             200,000  
Vesting portion of stock options             Upon achievement of certain product development objective(s), with the achievement of such objective(s) determined solely by the Lucid Diagnostics Inc. board of directors.  
2018 Long Term Incentive Equity Plan [Member] | Lucid Diagnostics Inc [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Stock-based compensation expense             $ 40,748  
2018 Long Term Incentive Equity Plan [Member] | Non-employees [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Weighted average fair value of stock options             $ 0.51